CVE-2021-25264
In multiple versions of Sophos Endpoint products for MacOS, a local attacker could execute...
In multiple versions of Sophos Endpoint products for MacOS, a local attacker could execute arbitrary code with administrator privileges.
Attack profile
How easy it is to exploit
- Attack vector
- Local
- Complexity
- Low
- Privileges needed
- High
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
In multiple versions of Sophos Endpoint products for MacOS, a local attacker could execute arbitrary code with administrator privileges.
- Record
CVE-2021-25264- CVSS 3.1
- 6.7 Medium
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 7.2 High
AV:L/AC:L/Au:N/C:C/I:C/A:C - Updated
- 2026-11-02
CVE List No score
In multiple versions of Sophos Endpoint products for MacOS, a local attacker could execute arbitrary code with administrator privileges.
- Record
CVE-2021-25264- Updated
- 2026-11-02
EUVDEUVD-2021-12175 No score
In multiple versions of Sophos Endpoint products for MacOS, a local attacker could execute arbitrary code with administrator privileges.
- Record
EUVD-2021-12175- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-jx3w-vv3x-mm9m
In multiple versions of Sophos Endpoint products for MacOS, a local attacker could execute...
In multiple versions of Sophos Endpoint products for MacOS, a local attacker could execute arbitrary code with administrator privileges.
- Record
GHSA-jx3w-vv3x-mm9m- CVSS 3.1
- 6.7 Medium
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-94
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2021-25264 is a medium vulnerability (CVSS 6.7) in Sophos Home, published May 17, 2021. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.31%, the 24th percentile. No source names a fixed version.